Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MCRB

+ Watchlist+ Portfolio

Seres Therapeutics, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.41
52-Week Range
$1.30 – $29.98
Market Cap
$14.68M
P/E (TTM)
—
EPS (TTM)
-5.01
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.68
PEG Ratio
—
Return on Equity
-144.35%
Return on Assets
-39.52%
Gross Margin
0.00%
Operating Margin
-3115.15%
Profit Margin
0.00%
Current Ratio
1.65
Debt/Equity
1.67
Total Debt
$35.77M
Free Cash Flow
$-38.83M
Revenue Growth
68.90%
Earnings Growth
—
Enterprise Value
$32.92M

Market Snapshot

About

Seres Therapeutics, Inc. is a microbiome therapeutics company developing bacterial consortia treatments for diseases including C. difficile infection and ulcerative colitis.